|
|
|
|
Impact of Subcutaneous Administration Sites on
the Clinical Pharmacokinetics of Lenacapavir, a
Long-Acting HIV Capsid Inhibitor: Does Body Site Matter?
|
|
|
IDWeek, 11-15 October 2023, Boston, Massachusetts, US
Allen Lat, Aryun Kim, Haeyoung Zhang, Stephen Lin, Eva Mortensen, Ramesh Palaparthy, Renu Singh
Gilead Sciences, Foster City, CA, US
|
|
|
|
|
|
|